Related Experiment Video
Updated: Aug 8, 2025

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
An Old Acquaintance: Could Adenoviruses Be Our Next Pandemic Threat?
Gustavo Saint-Pierre Contreras1,2, Daniel Conei Valencia3, Luis Lizama1
1Programa de Virología, ICBM, Facultad de Medicina, Universidad de Chile, Independencia 1027, Santiago 8380453, Chile.
Abstract:
Human adenoviruses (HAdV) are one of the most important pathogens detected in acute respiratory diseases in pediatrics and immunocompromised patients. In 1953, Wallace Rowe described it for the first time in oropharyngeal lymphatic tissue. To date, more than 110 types of HAdV have been described, with different cellular tropisms. They can cause respiratory and gastrointestinal symptoms, even urinary tract inflammation, although most infections are asymptomatic. However, there is a population at risk that can develop serious and even lethal conditions. These viruses have a double-stranded DNA genome, 25-48 kbp, 90 nm in diameter, without a mantle, are stable in the environment, and resistant to fat-soluble detergents. Currently the diagnosis is made with lateral flow immunochromatography or molecular biology through a polymerase chain reaction. This review aimed to highlight the HAdV variability and the pandemic potential that a HAdV3 and 7 recombinant could have considering the aggressive outbreaks produced in health facilities. Herein, we described the characteristics of HAdV, from the infection to treatment, vaccine development, and the evaluation of the social determinants of health associated with HAdV, suggesting the necessary measures for future sanitary control to prevent disasters such as the SARS-CoV-2 pandemic, with an emphasis on the use of recombinant AdV vaccines to control other potential pandemics.
Insights
Human adenoviruses (HAdV) cause significant respiratory illness, especially in children. This review explores HAdV variability and pandemic potential, advocating for recombinant adenovirus vaccines for future public health control.
Area of Science:
- Virology
- Public Health
- Immunology
Background:
- Human adenoviruses (HAdV) are significant pathogens causing acute respiratory diseases in pediatric and immunocompromised populations.
- Over 110 HAdV types exist, exhibiting diverse cellular tropisms and potential for severe, even lethal, conditions in at-risk groups.
- HAdV are stable, non-enveloped, double-stranded DNA viruses resistant to environmental factors and detergents.
Purpose of the Study:
- To highlight the genetic variability of HAdV.
- To assess the pandemic potential of HAdV, particularly recombinant strains like HAdV3 and 7.
- To propose sanitary control measures informed by social determinants of health for future pandemic prevention.
Main Methods:
- Review of existing literature on HAdV characteristics, diagnosis, and outbreaks.
- Analysis of HAdV variability and recombinant potential.
- Evaluation of social determinants of health impacting HAdV spread and severity.
Main Results:
- HAdV infections range from asymptomatic to severe, life-threatening conditions.
- Recombinant HAdV strains, such as HAdV3 and 7, have demonstrated aggressive outbreak potential in healthcare settings.
- Current diagnostic methods include lateral flow immunochromatography and PCR.
Conclusions:
- Understanding HAdV variability is crucial for predicting and managing outbreaks.
- Recombinant adenovirus vaccines show promise for controlling HAdV and preventing future pandemics.
- Integrating social determinants of health into sanitary control strategies is essential for effective public health preparedness.
Related Concept Videos
Viral Recombination
Viral Mutations
Viruses with RNA Genomes
Microorganisms in Medicine and Therapeutics
Vaccinations

